Vimarsana
Biggest News Aggregation in the World

Page 5 - Reverse Transcriptase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reverse Transcriptase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reverse Transcriptase Today - Breaking & Trending Today

Crystal structure of a human endogenous reverse transcriptase revealed - Vimarsana News

Crystal structure of a human endogenous reverse transcriptase revealed

The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and other diseases, according to a study co-authored by a Rutgers researcher.

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome - Vimarsana News

Antiretroviral drug used to treat HIV ameliorates cognitive deficits in mouse model of Down syndrome

Lamivudine, a commonly-used antiretroviral drug for treating HIV, improves cognition in a mouse model of Down syndrome, according to the findings of a joint new study by researchers at the Centre for Genomic Regulation (CRG) and the IrsiCaixa AIDS Research Institute, a center jointly promoted by the "la Caixa" Foundation and the Department of Health of the Generalitat de Catalunya.

Serologic testing captures missed children at risk for long Covid - Vimarsana News

Serologic testing captures missed children at risk for long Covid

A new study provides evidence of the utility of serologic testing in helping to pick up children with long Covid following missed diagnoses of COVID-19.

Enzyme Products, Reviews & Suppliers - Vimarsana News

Enzyme Products, Reviews & Suppliers

Read user reviews, compare products & request pricing from manufacturers of enzymes, including DNA polymerase, restriction enzymes & protease

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model - Vimarsana News

Demonstrating varying pathogenicity and tropism of SARS-CoV-2 variants in a feline model

In a recent study posted to the bioRxiv* pre-print server, researchers at Cornell University College of Veterinary Medicine and the University of Illinois Urbana-Champaign compared the infection dynamics, pathogenicity, and tissue tropism of multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants in adult cats.